Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
4.610
-1.255 (-21.40%)
Aug 3, 2026, 2:12 PM EDT - Market open
Lexaria Bioscience Market Cap
Lexaria Bioscience has a market cap or net worth of $7.62 million as of August 3, 2026. Its market cap has decreased by -54.11% in one year.
Market Cap
7.62M
Enterprise Value
6.16M
1-Year Change
-54.11%
Ranking
Category
Stock Price
$4.61
ChartMarket Cap Chart
Since January 12, 2021, Lexaria Bioscience's market cap has decreased from $18.20M to $7.62M, a decrease of -58.14%. That is a compound annual growth rate of -14.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 7.62M | -44.39% |
| Dec 31, 2025 | 13.70M | -62.67% |
| Dec 31, 2024 | 36.70M | 186.72% |
| Dec 29, 2023 | 12.80M | -12.33% |
| Dec 30, 2022 | 14.60M | -36.80% |
| Dec 31, 2021 | 23.10M | 26.92% |
| Jan 12, 2021 | 18.20M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences Holdings | 10.60M |
| GT Biopharma | 10.58M |
| Exicure | 10.20M |
| IN8bio | 10.19M |
| Vistagen Therapeutics | 9.89M |
| Curis | 9.78M |
| Theriva Biologics | 9.64M |
| BioCardia | 9.38M |